SABBY MANAGEMENT LLC 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-04 9:16 pm Sale |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
SABBY MANAGEMENT LLC | 3,095,410 11.000% |
-2,618,876 (-45.83%) |
Filing |
| 2021-12-09 10:11 am Purchase |
2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
SABBY MANAGEMENT LLC | 5,714,286 11.000% |
5,714,286 (New Position) |
Filing |